[CES 2025 Seoul Pavilion] Prevenotics '슬롯사이트 보스 Pro' – AI-Based Real-Time Endoscopic Solution for Gastrointestinal Cancer Preventive management

Gastrointestinal cancer affects millions globally, with gastric cancer being particularly challenging to detect early. Survival rates vary significantly depending on the stage of progression. However, systematic management from the precancerous stage can significantly reduce these risks. Addressing this critical issue, the innovative AI solution provider, 슬롯사이트 보스 (CEO Sooyoun Chang), will participate in the CES 2025 Seoul Pavilion as part of the Seoul AI Hub (booth#63416, 슬롯사이트 보스).

At this exhibition, Prevenotics will showcase '슬롯사이트 보스 Pro,' an AI-based real-time endoscopic diagnostic solution offering comprehensive diagnostic and preventive management from the precancerous stage to cancer. This system combines cutting-edge AI algorithms with a user-centric interface, enabling personalized diagnosis and surveillance management tailored to individual patients. The unique algorithms allow for more accurate detection and monitoring, setting a new standard in cancer prevention technology.

◇User-Centric Innovative Prevention Management, Targeting the Global Market with Real-Time AI Technology

Gastric cancer is deadly, with a global survival rate of only 20-40%. Systematic management at the precancerous stage allows for early detection and prevention, yet such management systems are still lacking. 슬롯사이트 보스 Pro was developed to address this unmet global need, presenting a new option in gastric cancer preventive management.

Currently, Prevenotics successfully operates 슬롯사이트 보스 Lite, a second-class medical device approved by the Ministry of Food and Drug Safety, in major hospitals across Korea. The upgraded Pro version is undergoing clinical research and validation. Additionally, through collaborations with LG Electronics, NVIDIA, and Canada's Mila Research Institute, Prevenotics has demonstrated its technological prowess and innovation, earning the 2024 Fix Innovation Award.

슬롯사이트 보스 Pro goes beyond mere diagnostic technology, offering systematic management options based on individual data. This solution is designed to support not only the diagnostic sites of medical institutions but also the everyday health management of high-risk individuals for cancer.

Through CES 2025, 슬롯사이트 보스 aims to demonstrate its technology, discover global medical partners, and provide customized solutions considering regional specificities, thereby expanding a new approach to gastrointestinal cancer prevention worldwide. We invite attendees to visit our booth for a product demonstration and explore partnership opportunities.

CEO Sooyoun Chang stated, "Gastrointestinal 슬롯사이트 보스 prevention through stratification and surveillance of high-risk patients should become a new norm. By providing effective preventive management to the potential 800 million high-risk patients worldwide through personalized AI technology, we ultimately aim to achieve '슬롯사이트 보스 Zero.' Our mission is to transform 슬롯사이트 보스 prevention into a global standard, impacting lives positively."

슬롯사이트 보스 hopes that CES 2025 will serve as a pivotal moment for its technology to reach countless patients worldwide in need of medical innovation, marking a significant step towards a healthier future.